SS

Srinivas Sarvepalli

Active Director Director DIN 02292051
DIN 02292051 First appointment Jul 2009 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 12 historical roles
Total affiliations 13 Since Jul 2009
Shareholding value •••• Premium profile

About Srinivas Sarvepalli

Data last updated:

Srinivas Sarvepalli is a Director at Sms Pharmaceuticals Limited (since 2019). The companies operate in Pharma, Manufacturing and Engineering. Sms Pharmaceuticals Limited reported revenue of ₹789 Cr (FY 2025). Earlier, Srinivas Sarvepalli was a Nominee Director at Swadeshi Polytex Ltd (2017–2018) and Nominee Director at Speck Systems Limited (2009–2011) and 10 more.

DIN 02292051
Primary Designation Director
Industry Pharma
First Appointment 25 Jul 2009
Oldest Company Age 38 yrs
Largest company Sms Pharmaceuticals Limited · ₹789 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sms Pharmaceuticals Limited L24239TG1987PLC008066
Director12 Aug 20191987₹789 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Swadeshi Polytex Ltd L25209UP1970PLC003320
Nominee Director18 Dec 20171970₹7.98 Cr (FY 2026)Active
Speck Systems Limited U29309TG1985PLC005246
Nominee Director25 Jul 20091985₹13.23 Cr (FY 2019)Active
National Textile Corpn Limited U74899DL1968GOI004866
Managing Director18 Dec 20171968₹44.39 Cr (FY 2023)Active
Apollo Design Apparel Parks Limited U17291MH2007GOI195397
Additional Director19 Dec 20172007₹21.45 Cr (FY 2023)Active
Managing Director01 May 20131983₹1,282 Cr (FY 2024)Active
Additional Director19 Dec 20172007₹29.90 Cr (FY 2023)Active
Additional Director18 Dec 20172007₹1.9 Lakh (FY 2023)Active
India United Textile Mill Limited U17291MH2007GOI195489
Additional Director20 Dec 20172007₹17.16 Cr (FY 2023)Active
Designated Partner31 May 20202019Strike Off
Director12 Feb 20142014Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Eprios Advisors Llp
Sms Pharmaceuticals Limited
Bharat Handloom Marketing Company Limited
Swadeshi Polytex Ltd
Premium access

Shareholding and investment profile for Srinivas Sarvepalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivas Sarvepalli

Srinivas Sarvepalli currently holds 1 directorship: Sms Pharmaceuticals Limited (Director, since 12 Aug 2019, revenue ₹789 Cr (FY 2025)).

Srinivas Sarvepalli was first appointed on 25 Jul 2009 as Nominee Director at Speck Systems Limited. The most recent appointment on record is 31 May 2020 at Eprios Advisors Llp.

Srinivas Sarvepalli held 12 earlier board appointments: Swadeshi Polytex Ltd (Nominee Director, 18 Dec 2017 to 31 May 2018); Speck Systems Limited (Nominee Director, 25 Jul 2009 to 21 Apr 2011); National Textile Corpn Limited (Managing Director, 18 Dec 2017 to 31 May 2018); Apollo Design Apparel Parks Limited (Additional Director, 19 Dec 2017 to 31 May 2018); National Handloom Development Corporation Limited (Managing Director, 01 May 2013 to 08 Jun 2018); and 7 more.

The current boards of Srinivas Sarvepalli's companies include Lakshmi Narayana Tammineedi (Sms Pharmaceuticals Limited), Ramesh Babu Potluri (Sms Pharmaceuticals Limited), Shanti Sree Bolleni (Sms Pharmaceuticals Limited), Shravan Kudaravalli (Sms Pharmaceuticals Limited), Sunkara Venkata Satya Shiva Prasad (Sms Pharmaceuticals Limited), Suresh Kumar Gangavarapu (Sms Pharmaceuticals Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available